grifols

Companies 29th September 2025

Neither Grifols, Rovi nor Almirall to be significantly affected by tariffs on pharmaceutical sector

Banc Sabadell | Trump said on social media that, starting on 1 October, all branded or patented pharmaceutical products will be subject to a 100% tariff, unless the company has begun to build a manufacturing facility in the United States. Assessment: Negative news due to the noise it may generate. However, details remain to be finalised, as we do not know whether companies that already had a presence in the…

Companies 16th September 2025

Grifols asks National Court to summon KPMG partners who signed 2021-2023 audits to testify in case

Alphavalue / Divacons | The Catalan company specialising in blood products is stepping up its legal offensive against Gotham City Research and has asked Court No. 4 of the National Court for the two KPMG partners who signed the 2021-2023 audits to testify in the case. The pharmaceutical company is seeking to strengthen its defence after the bearish attack that cost it around €9 million in January 2024. The Institute…

Companies, Relevant News Item 7th August 2025

CNMV imposes several fines on Grifols and directors for almost €1.4 million for deficiencies in financial reporting

Link Securities | The Spanish National Securities Market Commission (CNMV) has imposed several fines on Grifols (GRF) and its directors for a total of almost €1.4 million for deficiencies in its financial information and management reports, according to Expansión newspaper. The Official State Gazette (BOE) published on Wednesday a resolution dated 24 July by the CNMV announcing the penalties for very serious and serious infringements imposed on Grifols and several…

$Grifols to build new €160-million fractionation plant in Spain to double European production capacity$

Companies, Relevant News Item 18th July 2025

Grifols to build new €160-million fractionation plant in Spain to double European production capacity

Renta 4 | Grifols has resumed a project it has been working on since 2020 to build a new fractionation plant that will enable it to double its production capacity in Europe. The new factory will be located in Llica del Vall in the province of Barcelona, on land adjacent to its Parets del Valles complex, on an 80,000-square metre site that the company acquired for this purpose in 2018….

Relevant News Item 13th June 2025

Grifols’ takeover bid for Biotest, accepted by 2.11% of ordinary shares with voting rights (1.05% of capital)

Alphavalue/ Divacons | The Catalan plasma derivatives company announced yesterday that, once the period for acceptance of the delisting takeover bid for Biotest has ended, it will control 99.25% of the company. Biotest was delisted on 6 June, according to the information sent to the National Securities Market Commission (CNMV). The delisting offer was accepted by a total of 416,922 ordinary shares of Biotest and 3,002,804 non-voting preferred shares. In…

In the World 4th June 2025

US judge to investigate Gotham for defamation of Grifols in bearish report published in January 2024

Banco Sabadell: According to press reports, the U.S. District Court for the Southern District of New York has agreed to investigate Gotham City Research for defamation following the bearish report published on Grifols in January 2024. At the same time, it rejects four of the five charges brought by Grifols (illicit enrichment or interference with business relationships, among others). The court has also explicitly rejected the defendants’ attempt to invoke…

In Spain 3rd June 2025

Mason Capital, 3.174% owner of Grifols, backs company by supporting candidate list for election of next Board

Alphavalue/DIVACONS | The Mason Capital fund, which owns 3.174% of Grifols’ (GRF) class A shares, has expressed its support for the blood products company’s board of directors by backing the list of candidates proposed for election at the next ordinary general shareholders’ meeting, scheduled for Thursday, 5 June. Grifols: Buy, Target Price €14.6/share

European economy 7th May 2025

German stock market supervisor approves Grifols’ takeover bid for subsidiary Biotest at €43 per share

Link Securities | Grifols (GRF) informed the National Securities Market Commission (CNMV) that on Tuesday the German federal financial supervisory authority, the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), approved the publication of the offer document submitted by its subsidiary Grifols Biotest Holdings GmbH with the terms and conditions of the public takeover bid for delisting launched to all shareholders of Biotest AG to acquire all ordinary shares of Biotest, of which Grifols…

Spanish economy 11th April 2025

Brandes Investment increases stake in Grifols’ B shares to 16.4%

Alphavalue/DIVACONS | Brandes Investment Partners has taken advantage of the sharp fall in the stock market value of the Catalan company specialising in plasma products following the tariff crisis to increase its stake in the B shares (non-voting) to 16.4%, with an estimated value of €250 million. This position could be key if Brookfield decides to resume its takeover bid for the company. Grifols shares rose 6.63% on Thursday. Grifols:…

Relevant News Item 10th March 2025

Grifols loses over 5% after Securities Market Commission report slams financial management

CdM | Grifols shares lost more than 5% on the stock market on Monday. Last Friday, after the market had closed, a report was published by the National Securities Market Commission (CNMV) that was highly critical of the company’s financial management. According to the report sent by the CNMV to the investigating judge in the case, José Luis Calama, and to which “El Mundo” has had access, Grifols’ top management…

1 2 3 … 7 »